Reduces the effectiveness of diuretics; enhances the effects of anticoagulants, antiaggregation agents, fibrinolytics, adrenal hormones and GCS side effects and estrogens; reduces the effectiveness of antihypertensive agents and diuretics; enhances the hypoglycemic effect of sulfonylurea derivatives.<\/p>\n
<\/p>\n
Tenoxicam, a thienothiazine derivative of Oxycam, is a medicine from the NSAID group. In addition to its anti-inflammatory, analgesic and antipyretic effects, the drug also inhibits platelet aggregation. Tenoxicam exerts its anti-inflammatory effect by inhibiting the activity of COX isoenzymes involved in the metabolism of arachidonic acid, thereby inhibiting PG synthesis. Tenoxicam has no effect on lipoxygenase activity. In addition, tenoxicam inhibits several leukocyte functions, including phagocytosis and histamine release, and reduces active radicals at the site of inflammation.<\/p>\n
The drug is rapidly absorbed from the gastrointestinal tract in unchanged form. CMax<\/sub> is achieved 2 hours after taking the drug. If the drug is taken after a meal or with antacids, the rate of absorption is reduced, but not the extent of absorption. The median of T1\/2<\/sub> is 70 hours. Tenoxicam is completely absorbed; its bioavailability is 100 %. In the blood, 99 % of the active ingredient is bound to proteins.<\/p>\n The drug penetrates well into the synovial fluid, has a low systemic clearance and a long T1\/2<\/sub> so that tenoxicam can be taken once a day.<\/p>\n 2\/3 of the administered dose is excreted in the urine and 1\/3 in the faeces. No accumulation of tenoxicam is observed during long-term use; In this case, the active ingredient content in the serum is 10-15 \u00b5g\/ml.<\/p>\n Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, joint syndrome with exacerbation of gout, synovitis;<\/p>\n Pain syndrome (mild to moderate intensity): arthralgia, myalgia, neuralgia, migraine, toothache, headache, algodysmenorrhea;<\/p>\n Inflammatory and degenerative diseases of the musculoskeletal system that are accompanied by a pain syndrome, e.g. B. Sciatica, lumbago, epicondylitis.<\/p>\n The preparation is intended for symptomatic treatment, that is, it relieves pain and inflammation at the time of use and has no effect on the progression of the disease.<\/p>","protected":false},"excerpt":{"rendered":" Verringert die Wirksamkeit von Diuretika; verst\u00e4rkt die Wirkung von Antikoagulantien, Antiaggregationsmitteln, Fibrinolytika, Nebennierenhormonen und GCS-Nebenwirkungen und \u00d6strogenen; verringert die Wirksamkeit von blutdrucksenkenden Mitteln und Diuretika; verst\u00e4rkt die hypoglyk\u00e4mische Wirkung von Sulfonylharnstoffderivaten. Pharmakodynamik. Tenoxicam, ein Thienothiazin-Derivat von Oxycam, ist ein Arzneimittel aus der Gruppe der NSAID. Neben seiner entz\u00fcndungshemmenden, schmerzstillenden und fiebersenkenden Wirkung hemmt das Medikament […]<\/p>\n","protected":false},"author":1,"featured_media":5309,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"crb-meta-links":"","crb-meta-show":"","crb-meta-show-edited":"","crb-meta-use-manual":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-3362","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-artikel"],"yoast_head":"indications<\/h2>\n